Evolution of Technology

Carotid Artery Stents

During the first attempts at CAS, the embolic stroke rate was higher than standard CEA. Attempts at reducing this risk were first trialed with distal protecting devices. Initially, a balloon was inflated downstream to the carotid lesion which would prevent emboli from traveling onward to the brain. However once the balloon was deflated there still posed a stroke risk.

In an effort to continue to improve results, a filter was used in place of a balloon. While the filters provided somewhat better protection, they can miss microembolization and also create microemboli upon deployment and removal. This realization soon gave way to the flow reversal system, which has proven to have a very high stroke protection. Overall, CAS has proven to be non inferior to CEA and is incredibly useful in poor surgical CEA candidates.

Evolution of Procedure

Carotid Artery Revascularization

Since the advent of CEA in 1953, minimally invasive efforts have been developed using carotid artery stents. Carotid artery stenting (CAS) was initially developed for patients who were at high risk for stroke and were poor surgical candidates. Early attempts at carotid angioplasty were seen in the late 1990’s, and as technology has improved, it is being trialed in increasing patients.

It usually involves access through a transfemoral approach and is performed with local anesthesia with or without sedation. Most carotid artery stents use either a cobalt-chromium or nickel titanium stent. However, a slightly increased risk in periprocedural stroke and mortality with CAS has led to other minimally invasive options, such as the transcarotid approaches for carotid artery revascularization.